Given that ERBB4 suppresses anoikis and increases migration and invasion of ES cells in vitro, and enhances their metastatic capacity in vivo, we wondered whether ERBB4 expression correlates with metastatic disease in ES patients. This evidence concerns the gene ERBB4 and metastatic neoplasm.